Академический Документы
Профессиональный Документы
Культура Документы
Kelompok Tutorial 17 :
FAKULTAS KEDOKTERAN
UNIVERSITAS LAMPUNG
T.A. 2019-2020
Step 1
Patient details
Occupation
(e.g. name, Travel history (note if health-
home address, in 7 days
Demographic care worker or
home/mobile before the
information onset of laboratory
telephone
symptoms worker)
numbers)
Contact with
confirmed or Exposure
suspect human Clinical data − Laboratory
H5 cases in the history to symptoms data
7 days before animals
symptom onset
2. Pathophysiology
3. Type of Avian Influenza Virus
Influenza A viruses
infect humans and
Influenza B viruses
many different
circulates among Influenza C viruses Influenza D viruses
animals. The
humans and cause can infect both primarily affect
ability infect
seasonal humans and pigs cattle and are not
people and have
epidemics. Recent but infections are known to infect or
sustained human to
data showed seals generally mild and cause illness in
human
also can be are rarely reported. people.
transmission, can
infected.
cause an influenza
pandemic
.
Evidence suggests that some antiviral drugs, notably neuraminidase
inhibitor (oseltamivir, zanamivir), can reduce the duration of viral replication
and improve prospects of survival, however ongoing clinical studies are
needed. Emergence of oseltamivir resistance has been reported
2. Management of Avian
1. Type of Zoonosis
Influenza in Hospital
1. A general explanation of zoonoses in agriculture
field
National
Early warning
surveillance
and disease
and monitoring Animal health Veterinary
emergency
system for information public health
system (early
zoonotic system system
warning system
diseases in (Sikhnas). (Siskesmavet).
and emergency
livestock and
preparedness).
wildlife.
A. MANAGEMENT IN POLYCLINICS
• Pay attention to
general conditions,
Supporting
awareness, vital signs examination
(blood pressure,
pulse, breathing • Perform supporting
frequency, examinations in accordance Definitive
temperature). Monitor with Athe needs and (antiviral) therapy
conditions of the patient.
oxygen saturation
with pulse oxymetry
Clinical
Assessment
For adult patients All patients who meet t
Oxygen he criteria for severe sepsis and septic sho
Other therapies: ck: Acute Lung Injury (ALI), Acute Respi
therapy, fluid ratory Distress Syndrome (ARDS). - Seve
therapy, • Amoxicillin is the first choice for oral a re sepsis is sepsis accompanied by one of
ntibiotics in children <5 years. Alternati the disorders of organ functions, as below
adequate
ves are co-amoxiclav, ceflacor, erythro 1. Hypotension
nutrition etc. mycin, clarithromycin and azithromycin 2. Hyperlactatemia
Antipyretics • Giving corticosteroids on a regular bas 3. Renal: acute increase in serum creatini
is is not recommended because there ne> 176.8 mmol / l (2.0 mg / dl) or uri
the first choice i are no clinical trials, even potentially h ne output <0.5 ml / kg / hour for> 2 ho
s armful, which can extend the period of urs
viral replication and increase the risk o
paracetamol. f opportunistic infections.
4. Lung: Acute Lung Injury (ALI) with P
aO2 / FIO2 300 mmhg (P/F ratio)
• Under the above conditions, corticost 5. Liver: acute increase in bilirubin> 34.
eroids are considered for 2 µmol / l (2 mg / dl)
Supportive and sy
• Adult: Hydrocortisone or equivalent 6. Thrombocytopenia
mptomatic therapy methylprednisolone 0.5 1 mg /kg/day
divided in 3-4 doses in 24 hours (in di 7. Coagulopathy
vided doses every 8-6 hours).
• Children: Hydrocortisone 2 mg / kg I
V or equivalent Dexamethason 0.5 m
g / kg BW every 8 hours or Methylpre
dnisolone 1-2 mg / kg IV every 6 h. ICU entry criteria
Antivirals
- Treatment There are antiviral drugs that work as inhibitors of
neuramidase such as oseltamivir and zanamivir while Amantadin
and Rimantadin inhibit M2 protein.